Selected research
Market Structure
Global Fast-disintegrating Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fast-disintegrating Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fast-disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fast-disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fast-disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fast-disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fast-disintegrating Tablets include Teva, Johnson and Johnson, Merck, Mylan, Eli Lilly and Company, Pfizer, GSK, AstraZeneca and Otsuka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fast-disintegrating Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fast-disintegrating Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fast-disintegrating Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fast-disintegrating Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Fast-disintegrating Tablets Segment by Company
Teva
Johnson and Johnson
Merck
Mylan
Eli Lilly and Company
Pfizer
GSK
AstraZeneca
Otsuka
Conquer
Bristol-Myers Squibb
Fast-disintegrating Tablets Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Fast-disintegrating Tablets Segment by Application
CVS Diseases
Gastrointestinal Diseases
CNS Diseases
Other
Fast-disintegrating Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fast-disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fast-disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fast-disintegrating Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fast-disintegrating Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fast-disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fast-disintegrating Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fast-disintegrating Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Other
Applications
- CVS Diseases
- Gastrointestinal Diseases
- CNS Diseases
- Other
Companies covered
- Teva
- Johnson and Johnson
- Merck
- Mylan
- Eli Lilly and Company
- Pfizer
- GSK
- AstraZeneca
- Otsuka
- Conquer
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fast-disintegrating Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fast-disintegrating Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fast-disintegrating Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fast-disintegrating Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fast-disintegrating Tablets Market Dynamics
- 2.1 Fast-disintegrating Tablets Industry Trends
- 2.2 Fast-disintegrating Tablets Industry Drivers
- 2.3 Fast-disintegrating Tablets Industry Opportunities and Challenges
- 2.4 Fast-disintegrating Tablets Industry Restraints
3 Fast-disintegrating Tablets Market by Manufacturers
- 3.1 Global Fast-disintegrating Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Fast-disintegrating Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Fast-disintegrating Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fast-disintegrating Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fast-disintegrating Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fast-disintegrating Tablets Manufacturers, Product Type & Application
- 3.7 Global Fast-disintegrating Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fast-disintegrating Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fast-disintegrating Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Fast-disintegrating Tablets Tier 1, Tier 2, and Tier 3
4 Fast-disintegrating Tablets Market by Type
- 4.1 Fast-disintegrating Tablets Type Introduction
- 4.1.1 Anti-Psychotics Drug
- 4.1.2 Anti-Epileptics Drug
- 4.1.3 Other
- 4.2 Global Fast-disintegrating Tablets Sales by Type
- 4.2.1 Global Fast-disintegrating Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fast-disintegrating Tablets Sales by Type (2021-2032)
- 4.2.3 Global Fast-disintegrating Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Fast-disintegrating Tablets Revenue by Type
- 4.3.1 Global Fast-disintegrating Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Fast-disintegrating Tablets Revenue Market Share by Type (2021-2032)
5 Fast-disintegrating Tablets Market by Application
- 5.1 Fast-disintegrating Tablets Application Introduction
- 5.1.1 CVS Diseases
- 5.1.2 Gastrointestinal Diseases
- 5.1.3 CNS Diseases
- 5.1.4 Other
- 5.2 Global Fast-disintegrating Tablets Sales by Application
- 5.2.1 Global Fast-disintegrating Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fast-disintegrating Tablets Sales by Application (2021-2032)
- 5.2.3 Global Fast-disintegrating Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Fast-disintegrating Tablets Revenue by Application
- 5.3.1 Global Fast-disintegrating Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Fast-disintegrating Tablets Revenue Market Share by Application (2021-2032)
6 Global Fast-disintegrating Tablets Sales by Region
- 6.1 Global Fast-disintegrating Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fast-disintegrating Tablets Sales by Region (2021-2032)
- 6.2.1 Global Fast-disintegrating Tablets Sales by Region (2021-2026)
- 6.2.2 Global Fast-disintegrating Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fast-disintegrating Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fast-disintegrating Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fast-disintegrating Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fast-disintegrating Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fast-disintegrating Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fast-disintegrating Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fast-disintegrating Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fast-disintegrating Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fast-disintegrating Tablets Revenue by Region
- 7.1 Global Fast-disintegrating Tablets Revenue by Region
- 7.1.1 Global Fast-disintegrating Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fast-disintegrating Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Fast-disintegrating Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Fast-disintegrating Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fast-disintegrating Tablets Revenue (2021-2032)
- 7.2.2 North America Fast-disintegrating Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fast-disintegrating Tablets Revenue (2021-2032)
- 7.3.2 Europe Fast-disintegrating Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fast-disintegrating Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fast-disintegrating Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fast-disintegrating Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fast-disintegrating Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Fast-disintegrating Tablets Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Johnson and Johnson
- 8.2.1 Johnson and Johnson Company Information
- 8.2.2 Johnson and Johnson Business Overview
- 8.2.3 Johnson and Johnson Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson and Johnson Fast-disintegrating Tablets Product Portfolio
- 8.2.5 Johnson and Johnson Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Fast-disintegrating Tablets Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Mylan
- 8.4.1 Mylan Company Information
- 8.4.2 Mylan Business Overview
- 8.4.3 Mylan Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mylan Fast-disintegrating Tablets Product Portfolio
- 8.4.5 Mylan Recent Developments
- 8.5 Eli Lilly and Company
- 8.5.1 Eli Lilly and Company Company Information
- 8.5.2 Eli Lilly and Company Business Overview
- 8.5.3 Eli Lilly and Company Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Eli Lilly and Company Fast-disintegrating Tablets Product Portfolio
- 8.5.5 Eli Lilly and Company Recent Developments
- 8.6 Pfizer
- 8.6.1 Pfizer Company Information
- 8.6.2 Pfizer Business Overview
- 8.6.3 Pfizer Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pfizer Fast-disintegrating Tablets Product Portfolio
- 8.6.5 Pfizer Recent Developments
- 8.7 GSK
- 8.7.1 GSK Company Information
- 8.7.2 GSK Business Overview
- 8.7.3 GSK Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GSK Fast-disintegrating Tablets Product Portfolio
- 8.7.5 GSK Recent Developments
- 8.8 AstraZeneca
- 8.8.1 AstraZeneca Company Information
- 8.8.2 AstraZeneca Business Overview
- 8.8.3 AstraZeneca Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AstraZeneca Fast-disintegrating Tablets Product Portfolio
- 8.8.5 AstraZeneca Recent Developments
- 8.9 Otsuka
- 8.9.1 Otsuka Company Information
- 8.9.2 Otsuka Business Overview
- 8.9.3 Otsuka Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Otsuka Fast-disintegrating Tablets Product Portfolio
- 8.9.5 Otsuka Recent Developments
- 8.10 Conquer
- 8.10.1 Conquer Company Information
- 8.10.2 Conquer Business Overview
- 8.10.3 Conquer Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Conquer Fast-disintegrating Tablets Product Portfolio
- 8.10.5 Conquer Recent Developments
- 8.11 Bristol-Myers Squibb
- 8.11.1 Bristol-Myers Squibb Company Information
- 8.11.2 Bristol-Myers Squibb Business Overview
- 8.11.3 Bristol-Myers Squibb Fast-disintegrating Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bristol-Myers Squibb Fast-disintegrating Tablets Product Portfolio
- 8.11.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fast-disintegrating Tablets Value Chain Analysis
- 9.1.1 Fast-disintegrating Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fast-disintegrating Tablets Production Mode & Process
- 9.2 Fast-disintegrating Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fast-disintegrating Tablets Distributors
- 9.2.3 Fast-disintegrating Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst